Abstract Details

Title Relationship between Seizure Frequency Reduction and Health-Related Quality of Life in Conversion-to-Monotherapy and Adjunctive Therapy Trials of Eslicarbazepine Acetate

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P3 - (-)

Poster/Presentation
Number 229

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Fulton Velez PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Hailong Cheng	No disclosure on file
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Joyce A. Cramer (Yale University School of Medicine)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��